Patient Perspectives in Mantle Cell Lymphoma Clinical Research
Not yet recruiting
- Conditions
- Mantle Cell Lymphoma
- Registration Number
- NCT06049472
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical studies with a distinct emphasis on mantle cell lymphoma play a pivotal role in evaluating the safety and effectiveness of novel treatments for this disease. These trials are instrumental in ascertaining whether new medications surpass conventional therapies, providing substantial evidence to endorse their broad utilization.
This particular study stands out as it centers on the firsthand experiences of individuals battling mantle cell lymphoma who are actively engaged in a clinical trial featuring medicinal interventions. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this patient group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Confirmed diagnosis of mantle cell lymphoma
- No serious medical or psychiatric illness likely to interfere with participation in this clinical study.
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria
- Concurrent participation in another therapeutic clinical trial.
- Subject has an uncontrolled infection
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to enroll in a mantle cell lymphoma clinical study 3 months Rate of patients who remain in a mantle cell lymphoma clinical study to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States